Healio1h
FDA approves subcutaneous Merilog for glycemic control in diabetes
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
Novo Suffers Loss in Lawsuit Against Pharmacy’s Copycat Ozempic
Novo Nordisk A/S failed to convince a federal judge that a pharmacy in Florida making compounded versions of its diabetes and ...
BioSpace1d
Novo’s Semaglutide Shows Promise for Alcohol Use Disorder
The data, published in JAMA Psychiatry, add to the growing body of evidence supporting the use of GLP-1 receptor agonists for ...
Healthline15d
FDA Approves Ozempic to Help Treat Kidney Disease in People With Diabetes
The results of the FLOW (Evaluate Renal Function with Semaglutide Once Weekly) trial were presented at the 61st European Renal Association Congress in Stockholm last year. Novo Nordisk’s FLOW ...
WRAL16d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
drugmaker Novo Nordisk said Tuesday. A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease worsening by 24% in people who also ...
Business Wire16d
NVO INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Novo Nordisk ... 2.4 mg and 70.2% with semaglutide 2.4 mg.” On this news, the price of Novo Nordisk stock fell nearly 18%, according to the complaint. THE LEAD PLAINTIFF PROCESS: The Private ...
WLKY17d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
12;40;44;06 THESE MEDICATIONS MIMIC THAT NATURAL PROCESS ... drugmaker Novo Nordisk said Tuesday. A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced ...